These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2041455)

  • 1. Cell cycle arrest and cellular differentiation mediated by a cell surface sialoglycopeptide.
    Edson GD; Fattaey HK; Johnson TC
    Life Sci; 1991; 48(19):1813-20. PubMed ID: 2041455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor.
    Enebo DJ; Fattaey HK; Moos PJ; Johnson TC
    J Cell Biochem; 1994 Jun; 55(2):200-8. PubMed ID: 8089195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of growth-related gene expression and cell cycle synchronization by a sialoglycopeptide inhibitor.
    Fattaey HK; Bascom CC; Johnson TC
    Exp Cell Res; 1991 May; 194(1):62-8. PubMed ID: 1901795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of a naturally occurring cell surface growth inhibitor related to a previously described bovine sialoglycopeptide.
    Fattaey HK; Enebo DJ; Moos PJ; Johnson TC
    J Cell Biochem; 1993 May; 52(1):69-77. PubMed ID: 8320276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA synthesis and cell division by a cell surface sialoglycopeptide.
    Fattaey H; Johnson TC; Chou HH
    J Cell Physiol; 1989 May; 139(2):269-74. PubMed ID: 2715187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulators of cell proliferation.
    Johnson TC
    Pharmacol Ther; 1994; 62(1-2):247-65. PubMed ID: 7991645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a cell surface inhibitor in early signal transduction associated with the regulation of cell division and differentiation.
    Johnson TC; Enebo DJ; Moos PJ; Fattaey HK
    Trans Kans Acad Sci; 1992; 95(1-2):11-5. PubMed ID: 11537977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium influences sensitivity to growth inhibition induced by a cell surface sialoglycopeptide.
    Betz NA; Fattaey HK; Johnson TC
    J Cell Physiol; 1994 Dec; 161(3):553-61. PubMed ID: 7962136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hormone and growth factor responsive and resistant human breast cancer cells by CeReS-18, a cell regulatory sialoglycopeptide.
    Fattaey HK; Betz NA; Westhoff BA; Moos PJ; Johnson TC
    Breast Cancer Res Treat; 1997 Jan; 42(2):125-36. PubMed ID: 9138602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the tyrosine phosphatase antagonist orthovanadate in the study of a cell proliferation inhibitor.
    Enebo DJ; Hanek G; Fattaey HK; Johnson TC
    Trans Kans Acad Sci; 1993 Apr; 96(1-2):40-5. PubMed ID: 11537710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cytotoxicity of transformed cells but not normal cells by a sialoglycopeptide growth regulator in the presence of tumor necrosis factor.
    Woods KM; Fattaey H; Johnson TC; Chapes SK
    Biochem Biophys Res Commun; 1994 Nov; 205(1):215-20. PubMed ID: 7999026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    Jpn J Cancer Res; 1987 Sep; 78(9):921-31. PubMed ID: 3117748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a sialoglycopeptide on early events associated with signal transduction.
    Toole-Simms WE; Loder DK; Fattaey HK; Johnson TC
    J Cell Physiol; 1991 May; 147(2):292-7. PubMed ID: 2040660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of the mitogenic activity of bombesin by a cell surface sialoglycopeptide growth inhibitor.
    Johnson TC; Sharifi BG
    Biochem Biophys Res Commun; 1989 Jun; 161(2):468-74. PubMed ID: 2735903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of BALB/c mouse keratinocytes by TGF-beta 1 and CeReS-18 appears to act through distinct mechanisms.
    Betz NA; Fattaey HK; Johnson TC
    Exp Cell Res; 1996 Aug; 227(1):47-54. PubMed ID: 8806450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cell regulatory agent, CeReS-18, inhibits mouse 3T6 cell proliferation but not polyomavirus replication.
    An K; Paulsen AQ; Johnson TC
    Exp Cell Res; 2002 Jan; 272(2):209-15. PubMed ID: 11777346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of human fibroblast derived inhibitor on tumor and transformed cell proliferation and differentiation].
    Song Y; Wu K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):50-5. PubMed ID: 1831701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mammalian cell regulatory agent, CeReS-18, inhibits yeast cell proliferation but not bacterial replication.
    An K; Urban DB; Urban JE; Johnson TC
    Curr Microbiol; 2003 May; 46(5):353-8. PubMed ID: 12732963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.